A. Nechepurenko, N. Ilov, S. S. Durmanov, P. Shugaev, Andrey V. Ivanchenko, I. Suchkov, Khosni A. Bsharat, Andrey M. Lukin, Lyudmila G. Medyanсeva, V. Povarov
{"title":"Application of Hemostatic Agent “Haemoblock” for Pocket Hematoma Reduction. Design of the PEGAS study: a Multicenter Clinical Trial","authors":"A. Nechepurenko, N. Ilov, S. S. Durmanov, P. Shugaev, Andrey V. Ivanchenko, I. Suchkov, Khosni A. Bsharat, Andrey M. Lukin, Lyudmila G. Medyanсeva, V. Povarov","doi":"10.17816/cardar70497","DOIUrl":null,"url":null,"abstract":"Pocket hematoma (PH) is a common complication of pacemaker implantations which prolongs hospitalization and may demand surgical revision in some cases. According to the data from different researchers PH rate varies from 2 to 7%. It depends on number of factors including a need for anticoagulation therapy. We present a review of design of multicenter clinical trial evaluating safety and efficacy of application of hemostatic agent Haemoblock for pocket hematoma reduction in patients taking oral anticoagulants.","PeriodicalId":33934,"journal":{"name":"Journal of Cardiac Arrhythmias","volume":"107 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-06-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Cardiac Arrhythmias","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.17816/cardar70497","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Pocket hematoma (PH) is a common complication of pacemaker implantations which prolongs hospitalization and may demand surgical revision in some cases. According to the data from different researchers PH rate varies from 2 to 7%. It depends on number of factors including a need for anticoagulation therapy. We present a review of design of multicenter clinical trial evaluating safety and efficacy of application of hemostatic agent Haemoblock for pocket hematoma reduction in patients taking oral anticoagulants.